Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Turns out Cuba's been sitting on a breakthrough cancer treatment. ... lung cancer drug called Racotumomab, which encourages the immune system to ...
You think that your immune system is there to protect you. But what happens when it starts working against you? In the earliest stages of cancer ...
Genetic counseling linked to increased use of preventive ovary removal in women at high risk for ...
Many women with a family history of breast cancer who carry a BRCA ... the power of the immune system to treat cancer with minimal side effects.
A team of University of New Mexico Cancer Center researchers is developing ... cancer] over the years, to try to take advantage of the immune system.
PD-L1, or programmed death-ligand 1, is a protein that has been shown to play a role in suppressing the immune system during cancer and other ...
Dendritic cell (DC) vaccines — autologous DCs pulsed with tumour antigens ex vivo and re-injected into patients — have been used in an attempt to ...
In cancer immunotherapy, lymphocytes can be modified to express T cell receptors (TCRs) specific for particular tumour antigens. However, these ...
In 2013, Science Magazine named cancer immunotherapy the "Breakthrough of the Year." The article explored various types of cancer ...
“TNBC is a good target for cancer immunotherapy—in particular those that target PD-L1—for several reasons,” stated Leisha A. Emens, MD, PhD, ...
... antibody candidate in cancer immunotherapy. “Combining the expertise of the de Duve Institute/UCL/WELBIO in cancer immunology with arGEN-X's ...
Previous studies have linked moderate coffee consumption with a reduced risk of oral cancer, bladder cancer, colon cancer and esophageal cancer, ...
View 4082 Bladder Cancer posts, presentations, experts, and more. Get the professional knowledge you need on LinkedIn.
The oncologists Manuel Hidalgo, Director of the Clinical Research Programme of the Spanish National CancerResearch Centre (CNIO ), and Ignacio ...
PHILADELPHIA — The diabetes drug metformin was not associated with improved survival outcomes f or patients with pancreatic cancer, according to ...
Science Daily Cancer News
Findings on a novel therapeutic candidate for a genomically defined subset of hepatocellular carcinoma (HCC) patients with an aberrant fibroblast growth factor receptor 4 (FGFR4) pathway have been presented. BLU-554, a small molecule inhibitor of FGFR4, has been identified as a potential treatment option for up to 30 percent of HCC patients.
New results show that cancer rates in patients with the hepatitis C virus (HCV) were significantly increased compared to the non-HCV cohort. The researchers suggest an extrahepatic manifestation of HCV may be an increased risk of cancer.
A new study shows that by using genomic analyses to understand how and when carcinogenic mutations occur in patients with hepatocellular carcinoma, it is possible to identify specific molecular profiles. It is hoped that these molecular profiles will help identify which patients would benefit from specific anticancer treatments.
Tambahkan Komentar